Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of **alginate** and **coenzyme Q10** most plausibly used as a nutraceutical or supplement-style formulation rather than a defined approved pharmaceutical product. In such products, alginate typically functions as a polysaccharide carrier, gel-forming matrix, or gastroretentive and mucoadhesive excipient that can improve stability or delivery, while coenzyme Q10 is a lipophilic redox cofactor and antioxidant involved in mitochondrial electron transport. The combination has been described in formulation and preclinical contexts to enhance coenzyme Q10 stability and oral or topical delivery, but there is no clear evidence that \"alginate + coenzyme Q10\" corresponds to a single widely established branded drug with a standardized composition, developer, or regulatory status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alginate + coenzyme Q10.